Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gut

• Publication date

  2001-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gut.48.2.251PMID 11156649PMCID PMC1728189
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Follow-up study of 582 liver cirrhosis patients for 26 years in Japan.

  2008cited by this paper
• [Prognostic factors in patients with hepatocellular carcinoma].

  2001cited by this paper
• Early detection of hepatocellular carcinoma increases the chance of treatment: Hong Kong experience

  2000cited by this paper
• Natural history of untreated nonsurgical hepatocellular carcinoma: Rationale for the design and evaluation of therapeutic trials

  1999cited by this paper
• Gains in life expectancy from medical interventions--standardizing data on outcomes.

  1998cited by this paper
• Screening for hepatocellular carcinoma

  1998cited by this paper
• Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

  1996cited by this paper
• Ultrasound follow-up of patients at risk for hepatocellular carcinoma: results of a prospective study on 360 cases.

  1996cited by this paper
• Enzymatic cytochemistry, DNA ploidy and AgNOR quantitation in hepatocellular nodules of uncertain malignant potential in liver cirrhosis

  1996cited by this paper
• Cost-effectiveness of screening for detection of small hepatocellular carcinoma in western patients with Child-Pugh class A cirrhosis.

  1996cited by this paper
• Recommendations for Reporting Cost-effectiveness Analyses

  1996cited by this paper
• Efficacy of a surveillance program for early detection of hepatocellular carcinoma

  1996cited by this paper
• Liver cell dysplasia is a major risk factor for hepatocellular carcinoma in cirrhosis: a prospective study.

  1995cited by this paper
• Terminology of nodular hepatocellular lesions.

  1995cited by this paper
• No treatment, resection and ethanol injection in hepatocellular carcinoma: a retrospective analysis of survival in 391 patients with cirrhosis. Italian Cooperative HCC Study Group.

  1995cited by this paper
• Terminology of nodular hepatocellular lesions

  1995cited by this paper
• Prospective study of screening for hepatocellular carcinoma in Caucasian patients with cirrhosis.

  1994influential reference
• Mass screening for hepatocellular carcinoma: Experience in Hokkaido, Japan

  1994cited by this paper
• Screening for hepatocellular carcinoma in patients with Child's A cirrhosis: an 8-year prospective study by ultrasound and alphafetoprotein.

  1994influential reference
• A multivariate analysis of risk factors for hepatocellular carcinogenesis: A prospective observation of 795 patients with viral and alcoholic cirrhosis

  1993cited by this paper
• Risk factors for hepatocellular carcinoma among patients with chronic liver disease.

  1993influential reference
• Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy.

  1993cited by this paper
• Natural history of small untreated hepatocellular carcinoma in cirrhosis: A multivariate analysis of prognostic factors of tumor growth rate and patient survival

  1992cited by this paper
• Hepatocellular carcinoma in Italian patients with cirrhosis.

  1991influential reference
• Costs of Breast Cancer and the Cost-Effectiveness of Breast Cancer Screening

  1991cited by this paper
• Prognostic factors of hepatocellular carcinoma in the west: A multivariate analysis in 206 patients

  1990cited by this paper
• Prospective study of early detection of hepatocellular carcinoma in patients with cirrhosis

  1990influential reference
• A clinician's guide to cost-effectiveness analysis.

  1990cited by this paper
• α‐fetoprotein monitoring in chinese patients with chronic hepatitis B virus infection: Role in the early detection of hepatocellular carcinoma

  1989cited by this paper
• Early detection of hepatocellular carcinoma in patients with cirrhosis by alphafetoprotein, ultrasound and fine-needle biopsy.

  1989cited by this paper
• Early detection of hepatocellular carcinoma associated with cirrhosis by ultrasound and alfafetoprotein: a prospective study.

  1988influential reference
• Prognostic factors in patients with hepatocellular carcinoma attempts for the selection of patients with prolonged survival

  1987cited by this paper
• Early detection of hepatocellular carcinoma in patients with chronic type B hepatitis. A prospective study.

  1986cited by this paper
• Natural history of hepatocellular carcinoma and prognosis in relation to treatment study of 850 patients

  1985cited by this paper
• Screening methods for early detection of hepatocellular carcinoma

  1985influential reference
• Early detection of hepatocellular carcinoma by real‐time ultrasonography. A prospective study

  1985cited by this paper
• The distinction between cost and charges.

  1982cited by this paper
• Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples.

  1977cited by this paper
• Transection of the oesophagus for bleeding oesophageal varices

  1973cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Maximum utilization of the life table method in analyzing survival.

  1958cited by this paper

• Cost-effectiveness of the GAAD algorithm for hepatocellular carcinoma surveillance of patients with compensated cirrhosis: a model-based analysis using Italian real-world data.

  2026cites this paper
• Association of Hepatitis B Virus Polymerase/Surface Gene Overlap Mutations Developed in Nucleos(t)id Analogue Treatments of Chronic Hepatitis B with Hepatocellular Carcinoma

  2025cites this paper
• Serological Exosome Metabolic Biopsy of Hepatocellular Carcinoma via Designed Core-Shell Nanoparticles.

  2024cites this paper
• A history of the treatment of primary liver cancer.

  2024cites this paper
• Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease.

  2024cites this paper
• Short and long-term outcomes after minimally invasive liver resection for single small hepatocellular carcinoma: An analysis of 714 patients from the IGoMILS (Italian group of minimally invasive liver surgery) registry.

  2023cites this paper
• Adding MRI as a Surveillance Test for Hepatocellular Carcinoma in Patients with Liver Cirrhosis Can Improve Prognosis

  2023cites this paper
• Identifying hepatocellular carcinoma patients with survival benefits from surgery combined with chemotherapy: based on machine learning model

  2022cites this paper
• Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach

  2022cites this paper
• Predictive Role for Serum Aldo-Keto Reductase Family1 Member B10 for Early Detection of Hepatocellular Carcinoma in Egyptian Patients

  2022cites this paper
• An MRI-Based Radiomic Model for Individualized Prediction of Hepatocellular Carcinoma in Patients With Hepatitis B Virus-Related Cirrhosis

  2022cites this paper
• Reappraisal of the roles of alpha-fetoprotein in hepatocellular carcinoma surveillance using large-scale nationwide database and hospital-based information.

  2022cites this paper
• Protein Kinase C Delta Is a Novel Biomarker for Hepatocellular Carcinoma

  2022cites this paper
• Contrast-enhanced ultrasound Liver Imaging Reporting and Data System: Lights and shadows in hepatocellular carcinoma and cholangiocellular carcinoma diagnosis

  2022cites this paper
• Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH.

  2021cites this paper
• Is Ultrasound a Viable Imaging Modality for the Diagnosis of Hepatocellular Carcinoma? A Cross-Sectional Study

  2021cites this paper
• Surveillance of patients with cirrhosis remains suboptimal in the United States.

  2021cites this paper
• A Systematic Review and Narrative Synthesis of Health Economic Evaluations of Hepatocellular Carcinoma Screening Strategies.

  2021cites this paper
• Hepatocellular Cancer

  2021cites this paper
• Ultrasound or Sectional Imaging Techniques as Screening Tools for Hepatocellular Carcinoma: Fall Forward or Move Forward?

  2021cites this paper
• Sensing and imaging of exosomal CD26 secreted from cancer cells and 3D colorectal tumor model using a novel near-infrared fluorogenic probe.

  2021cites this paper
• Diagnosis and treatment of hepatocellular carcinoma. Update of the consensus document of the AEEH, AEC, SEOM, SERAM, SERVEI, and SETH

  2021cites this paper
• Role of diffusion weighted MRI in patients with hepatocellular carcinoma: prediction and assessment of response to trans-arterial chemoembolization

  2021cites this paper
• Surveillance for hepatocellular carcinoma at the community level: Easier said than done

  2021cites this paper
• Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.

  2021cites this paper
• Liver Imaging Reporting and Data System: Review of Pros and Cons

  2021cites this paper
• Clinicopathological assessment of steatohepatitic hepatocellular carcinoma.

  2021cites this paper
• Effects of miRNA-140 on the Growth and Clinical Prognosis of SMMC-7721 Hepatocellular Carcinoma Cell Line

  2021cites this paper
• Liver Cancer

  2020cites this paper
• HIGH VALUES OF LIVER STIFFNESS PLAY AN IMPORTANT ROLE IN STRATIFYING THE RISK OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC HEPATITIS C PATIENTS.

  2020cites this paper
• Carcinoma hepatocelular

  2020cites this paper
• Integrated Model for Patient-Centered Advanced Liver Disease Care.

  2020cites this paper
• Assessment the Association of Fatty Acid Binding Protein 1 with Hepatocellular Carcinoma.

  2020cites this paper
• COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma

  2020cites this paper
• Argentinian clinical practice guideline for surveillance, diagnosis, staging and treatment of hepatocellular carcinoma.

  2020cites this paper
• Epidemiological profile of cancer patients attending tertiary care teaching hospital: a record based retrospective study

  2020cites this paper
• Current status of image-based surveillance in hepatocellular carcinoma

  2020cites this paper
• Screening for hepatocellular carcinoma in chronic liver disease: a systematic review and meta-analysis of randomized controlled trials comparing screening methodologies

  2020cites this paper
• Genetics of alcohol-related hepatocellular carcinoma - its role in risk prediction

  2020cites this paper
• Addressing the worldwide hepatocellular carcinoma: epidemiology, prevention and management.

  2020cites this paper
• Accuracy of ultrasound in detection of Hepatocellular Carcinoma in cirrhotic patients.

  2020cites this paper
• Liver Ultrasonography

  2020cites this paper
• Changes in serum fibronectin levels predict tumor recurrence in patients with early hepatocellular carcinoma after curative treatment

  2020cites this paper
• Evaluation and impact of different biomarkers for early detection of hepatocellular carcinoma

  2020cites this paper
• Evaluation of efficacy, safety and treatment-related outcomes of percutaneous radiofrequency ablation versus partial hepatectomy for small primary liver cancer meeting the Milan criteria: A systematic review and meta-analysis of randomized controlled trials.

  2020cites this paper
• GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis.

  2019cites this paper
• Surveillance of hepatocellular carcinoma by medical imaging.

  2019cites this paper
• Development of Quality Measures in Cirrhosis by the Practice Metrics Committee of the American Association for the Study of Liver Diseases

  2019cites this paper
• Long Non-Coding RNA NEAT1 Promoted Hepatocellular Carcinoma Cell Proliferation and Reduced Apoptosis Through the Regulation of Let-7b-IGF-1R Axis

  2019cites this paper
• Unique Biological Activity and Potential Role of Monomeric Laminin-γ2 as a Novel Biomarker for Hepatocellular Carcinoma: A Review

  2019cites this paper
• Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians

  2019cites this paper
• Clinical Application of Liver Stiffness Measurement for Assessing the Risk of Hepatocellular Carcinoma

  2019cites this paper
• Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma.

  2019cites this paper
• Acidic pH-Activated Gas-Generating Nanoparticles with Pullulan Decorating for Hepatoma-Targeted Ultrasound Imaging.

  2019cites this paper
• Autoimmune hepatitis: Epidemiology, prognosis and follow-up

  2019cites this paper
• Hepatocellular Carcinoma: Diagnosis and Prognosis

  2019cites this paper
• Long Non-Coding RNA NEAT1 Promoted Hepatocellular Carcinoma Cell Proliferation and Reduced Apoptosis Through the Regulation of Let-7b-IGF-1R Axis

  2019cites this paper
• Sensitive diagnosis of alpha-fetoprotein by a label free nanoaptasensor designed by modified Au electrode with spindle-shaped gold nanostructure

  2019cites this paper
• Automatic hepatocellular carcinoma lesion detection with dynamic enhancement characteristic from multi-phase CT images

  2019cites this paper
• DEVELOPMENT AND CHARACTERISATION OF MAGNETICALLY RESPONSIVE AND ACTIVE AGENT LOADED ALGINATE BASED MICROSPHERES TO BE USED IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA ( HCC ) HEPATOSELLÜLER KARSİNOM ( HSK )

  2019cites this paper
• Alzheimer's Disease Diagnosis Using Enhanced Inception Network Based on Brain Magnetic Resonance Image

  2019cites this paper
• Magnetic Resonance Imaging With Extracellular Contrast Detects Hepatocellular Carcinoma With Greater Accuracy Than With Gadoxetic Acid or Computed Tomography.

  2019cites this paper
• FIB-4 Is a Potential Tool for Hepatocellular Carcinoma Risk Stratification in Ethnically Diverse Chronic Hepatitis B Patients When Using Specific Cutoff Values

  2019cites this paper
• Surveillance for Hepatocellular Carcinoma: Does the Place Where Ultrasound Is Performed Impact Its Effectiveness?

  2018cites this paper
• Hepatocellular Carcinoma Screening Utilising Serum Alpha-Fetoprotein Measurement and Abdominal Ultrasound Is More Effective than Ultrasound Alone in Patients with Non-viral Cirrhosis

  2018cites this paper
• De novo hepatocellular carcinoma occurrence in hepatitis C cirrhotics treated with direct-acting antiviral agents

  2018cites this paper
• Hepatocellular carcinoma.

  2018cites this paper
• EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma.

  2018cites this paper
• MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker

  2018cites this paper
• A Glycomarker for Short-term Prediction of Hepatocellular Carcinoma: A Longitudinal Study With Serial Measurements

  2018cites this paper
• Upregulation of miR-200b Inhibits Hepatocellular Carcinoma Cell Proliferation and Migration by Targeting HMGB3 Protein

  2018cites this paper
• Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis.

  2018cites this paper
• Comparison of hepatic arterial infusion chemotherapy between 5‐fluorouracil‐based continuous infusion chemotherapy and low‐dose cisplatin monotherapy for advanced hepatocellular carcinoma

  2018cites this paper
• Hepatocellular carcinoma surveillance with ultrasound-cost-effectiveness, high-risk populations, uptake.

  2018cites this paper
• Effect of the Wnt/β‐catenin signaling pathway on apoptosis, migration, and invasion of transplanted hepatocellular carcinoma cells after transcatheter arterial chemoembolization in rats

  2018cites this paper
• Hepatocellular carcinoma: Epidemiology, pathogenesis and surveillance - implications for sub-Saharan Africa.

  2018cites this paper
• Predictors of Ultrasound Failure to Detect Hepatocellular Carcinoma

  2018influential citation
• Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma

  2018cites this paper
• Ablative techniques in hepatocellular carcinoma treatment

  2018influential citation
• The Diagnostic Performance of Liver MRI without Intravenous Contrast for Detecting Hepatocellular Carcinoma: A Case-Controlled Feasibility Study

  2018cites this paper
• MeCP2 level is associated with hepatocellular carcinoma development in chronic hepatitis B patients under antiviral therapy.

  2018cites this paper
• SND1-Targeted Gene Therapy for Hepatocellular Carcinoma

  2018cites this paper
• Chapter 1 Epidemiology and Prevention of Viral Hepatitis B and C

  2018cites this paper
• Stratified alpha-fetoprotein pattern accurately predicts mortality in patients with acute-on-chronic hepatitis B liver failure

  2018cites this paper
• Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis

  2018cites this paper
• The role of imaging in screening special feaTure: review arTicle hepatocellular carcinoma surveillance with ultrasound— cost-effectiveness, high-risk populations, uptake

  2018cites this paper
• Surveillance, Prevention and Surgical Treatments for Hepatocellular Carcinoma

  2018cites this paper
• Hepatocellular carcinoma surveillance: Eastern and Western perspectives

  2018cites this paper
• A potential clinical based score in hepatitis C virus cirrhotic patients to exclude small hepatocellular carcinoma

  2018influential citation
• Sustained efficacy of adjuvant immunotherapy with cytokine-induced killer cells for hepatocellular carcinoma: an extended 5-year follow-up

  2018cites this paper
• Hepatocellular carcinoma: Prevention and screening

  2018cites this paper
• Contrast enhanced ultrasound identifies hepatocellular carcinoma in cirrhosis: a large multicenter retrospective study

  2017cites this paper
• Diffusion‐weighted MRI for hepatocellular carcinoma screening in chronic liver disease: Direct comparison with ultrasound screening

  2017cites this paper
• Development of Risk Prediction Model for Hepatocellular Carcinoma Progression of Indeterminate Nodules in Hepatitis B Virus-Related Cirrhotic Liver

  2017cites this paper
• Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma: Systematic Review of Randomized Controlled Trials with Meta-Analysis and Trial Sequential Analysis.

  2017cites this paper
• Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.

  2017cites this paper
• Wisteria floribunda agglutinin‐positive human Mac‐2 binding protein predicts the risk of HBV‐related liver cancer development

  2017cites this paper
• An Updated Portrait of Pathogenesis, Molecular Markers and Signaling Pathways of Hepatocellular Carcinoma.

  2017cites this paper
• Surveillance of the Patients with High Risk of Hepatocellular Cancer

  2017cites this paper
• Mortality Associated with Hepatobiliary Disease in Portugal between 2006 and 2012

  2017cites this paper